Netherlands Expands Investment Controls in Technology Sectors

By Patricia Miller

Jun 09, 2026

2 min read

The Netherlands strengthens investment controls on sensitive tech including AI and biotech, requiring foreign firms to undergo regulatory scrutiny.

The Netherlands has recently tightened its controls on foreign investments in the technology sector. In June 2026, the Dutch government announced an expansion of its foreign investment screening regime under the Vifo Act. This new framework now covers six additional categories of sensitive technologies, including artificial intelligence and biotechnology, broadening its initial focus that began in 2023 with semiconductors and quantum computing.

What types of technologies are now included?

The expanded categories that will trigger regulatory scrutiny include:

  • Artificial intelligence
  • Biotechnology
  • Advanced materials and nanotechnology
  • Sensor and navigation technology
  • Nuclear technology for medical purposes

As foreign entities seek to acquire control over Dutch firms in these sectors, they will now face heightened screening requirements. This formal proposal was suggested in late December 2024, with implementation expected by 2026. The Vifo Act was first introduced on June 1, 2023, and its expansion signifies a strategic effort to safeguard the Netherlands’ technological sovereignty.

How does this affect global investment dynamics?

The Netherlands is responding to a broader trend in the European Union and beyond. The EU established its foreign direct investment (FDI) screening regulation in 2020, urging member states to reinforce national mechanisms. Similarly, the UK adopted its National Security and Investment Act in 2022. The semiconductor industry has been a major driver for the Netherlands, especially given the presence of ASML, a key player in the global chip supply chain. The government’s restrictions on exports of advanced lithography equipment have already illustrated its commitment to protecting vital technological assets.

What should investors consider?

From now on, mergers and acquisitions involving Dutch AI and biotech companies will require regulatory approval prior to foreign entities concluding these deals. Venture capital and private equity firms must evaluate their fund structures carefully, especially if foreign limited partners are involved, as this could trigger screening requirements based on ultimate beneficial ownership.

It’s notable that this expansion does not directly impact the crypto and digital asset sector, as the new categories focus on applied sciences rather than blockchain technology or financial systems. Investors must stay informed and prepared for potential changes in the landscape of Dutch technology investments as these new regulations take effect, ensuring they remain compliant and strategically positioned.

Important Notice And Disclaimer

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.